246
Views
4
CrossRef citations to date
0
Altmetric
Original Articles: Research

Suppression of cytomegalovirus-specific CD8+T cells by everolimus

, , , , , , , & show all
Pages 1144-1150 | Received 17 Apr 2013, Accepted 30 Jun 2013, Published online: 31 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mark DeBenedette, Alicia Gamble, Marcus Norris, Joe Horvatinovich & Charles A. Nicolette. (2023) A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma. Human Vaccines & Immunotherapeutics 19:2.
Read now

Articles from other publishers (3)

Jiju Mani, Lei Wang, Angela G. Hückelhoven, Anita Schmitt, Alma Gedvilaite, Nan Jin, Christian Kleist, Anthony D. Ho & Michael Schmitt. (2016) Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance. Oncotarget 8:2, pages 2485-2500.
Crossref
Oliver Witzke, Claudia Sommerer & Wolfgang Arns. (2016) Everolimus immunosuppression in kidney transplantation: What is the optimal strategy?. Transplantation Reviews 30:1, pages 3-12.
Crossref
G Malcherek, N Jin, A G Hückelhoven, J Mani, L Wang, U Gern, A Diehlmann, P Wuchter, A Schmitt, B Chen, A D Ho & M Schmitt. (2014) Mesenchymal stromal cells inhibit proliferation of virus-specific CD8+ T cells. Leukemia 28:12, pages 2388-2394.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.